In an effort to prepare for future health emergencies, the World Health Organization (WHO) has adopted a resolution geared toward delivering higher quality data and improving the conduct and coordination of clinical trials around the world.

At its crux, the resolution, adopted during the WHO’s seventy-fifth assembly, calls for faster reporting of both positive and negative trial results by registering trials in a public, international registry system, while urging individual countries to build up their own research capabilities to meet global design, conduct and participant protection standards.

In addition, it encourages the use of standardized data protocols and “investment in well-designed clinical trials, including through clinical trials networks, that are developed in collaboration with affected communities,” especially in lower-income nations. It also recognizes the pressing need to improve trial diversity to more accurately reflect and understand the populations that will actually use the interventions being evaluated, an issue that is seen by the FDA as a serious target for today’s trials and a critical public health issue.

Read the full resolution here: https://bit.ly/3z9UlQm.